You have 9 free searches left this month | to do more

kd025

Kd025 is a drug used to treat Hepatic Impairment, Idiopathic Pulmonary Fibrosis, and Psoriasis Vulgaris. Kd025 is being actively studied in 1 study and prior, has been studied in 2.

Top SponsorsTop SitesTop Investigators
Kadmon Corporation, LLCAdvanced Pharma CR, LLC
Altoona Center for Clinical Research
Arrowhead Health Centers
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
K
Recruiting
  • Hepatic Impairment
  • KD025
  • Rialto, California
  • +4 more
2022-03-08
Mar 8, 2022
K
Completed
  • Psoriasis Vulgaris
  • KD025
  • Glendale, Arizona
  • +8 more
2021-10-01
Oct 1, 2021
K
Completed
  • Idiopathic Pulmonary Fibrosis
  • KD025
  • BSC
  • Phoenix, Arizona
  • +9 more
2021-07-23
Jul 23, 2021